Athersys Operating Expenses 2011-2025 | ATHX

Annual Operating Expenses Athersys

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	79.8 M	51.1 M	50 M	37 M	33.1 M	29.1 M	30.6 M	26.9 M	24.7 M	24.1 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
79.8 M	24.1 M	38.6 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Arbutus Biopharma Corporation ABUS	96.2 M	$ 4.86	3.08 %	$ 807 M	Canada
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Aclaris Therapeutics ACRS	92.7 M	$ 3.22	-1.08 %	$ 249 M	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Aptevo Therapeutics APVO	-31.8 M	$ 1.05	-7.08 %	$ 290 K	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 0.27	-4.88 %	$ 588 M	Israel
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Catalyst Biosciences CBIO	176 M	$ 13.58	-3.62 %	$ 894 M	USA
Ascendis Pharma A/S ASND	338 M	$ 216.09	-1.96 %	$ 5 B	Danmark
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.14	-4.15 %	$ 7.55 B	Australia
Celldex Therapeutics CLDX	58.1 M	$ 27.1	-1.51 %	$ 1.75 M	USA
Corcept Therapeutics Incorporated CORT	189 M	$ 88.16	0.19 %	$ 9.1 B	USA
Catalyst Pharmaceuticals CPRX	190 M	$ 24.27	2.75 %	$ 2.87 B	USA
CureVac N.V. CVAC	88.9 M	$ 5.02	-0.59 %	$ 934 M	Germany
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
BioVie BIVI	18.1 M	$ 1.4	-3.45 %	$ 2.07 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	141 M	-	-15.15 %	$ 60.3 M	Britain
BioNTech SE BNTX	512 M	$ 93.87	-0.99 %	$ 27.2 B	Germany
Aeglea BioTherapeutics AGLE	209 M	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Dynavax Technologies Corporation DVAX	137 M	$ 10.8	-	$ 1.4 B	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	168 M	$ 26.2	3.68 %	$ 1.27 B	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Anika Therapeutics ANIK	51.6 M	$ 9.57	0.1 %	$ 140 M	USA
Eton Pharmaceuticals ETON	22.3 M	$ 15.96	-4.42 %	$ 409 M	USA
Evogene Ltd. EVGN	28 M	$ 1.07	-0.51 %	$ 27.9 M	Israel
Exelixis EXEL	598 M	$ 41.43	1.35 %	$ 12 B	USA
Arena Pharmaceuticals ARNA	427 M	-	-6.81 %	$ 3.04 B	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Axon Enterprise AXON	1.18 B	$ 548.8	-2.74 %	$ 41.6 B	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Foghorn Therapeutics FHTX	125 M	$ 4.36	-1.8 %	$ 239 M	USA
Aytu BioScience AYTU	53.7 M	$ 2.39	3.91 %	$ 15 M	USA
AstraZeneca PLC AZN	17.6 B	$ 91.03	1.34 %	$ 96.9 B	Britain
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
Burford Capital Limited BUR	106 M	$ 8.85	-1.72 %	$ 1.45 B	Britain
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Biohaven Pharmaceutical Holding Company Ltd. BHVN	1.07 B	$ 11.36	-1.47 %	$ 735 M	USA
Biogen BIIB	5.39 B	$ 174.34	0.14 %	$ 25.4 B	USA